Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2023
Reporting Period: First quarter ended March 31, 2023
This filing announces the issuance of a press release regarding the Company's financial results for the first quarter of 2023. A business update conference call was scheduled for the same date.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing serves as a notification of the results rather than a detailed financial statement.
Material Changes
The filing text does not provide specific data to compare against prior periods or identify material changes in financial performance.
Guidance, Outlook, and Risks
Management Commentary: The Company announced a business update via conference call on May 12, 2023, at 9:00 am EST.
Additional Information: Materials related to the results are available on the Company website at www.sanuwave.com/investors.
Legal Disclaimer: Information in Item 2.02 and attached exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, cash position) by reviewing the attached Press Release (Exhibit 99.1) or the Company's investor relations website.
- Confirm the details of the business update provided during the May 12, 2023, conference call.
- Review the full text of the press release for any forward-looking statements or risk factors not detailed in this 8-K summary.